Cargando…
Cardiovascular Hospitalizations, Influenza Activity, and COVID-19 Measures
Autores principales: | Myhre, Peder L., Grundvold, Irene, Paulsen, Trine H., Omland, Torbjørn, Schirmer, Henrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515472/ https://www.ncbi.nlm.nih.gov/pubmed/32757861 http://dx.doi.org/10.1161/CIRCULATIONAHA.120.049118 |
Ejemplares similares
-
Established Cardiovascular Biomarkers Provide Limited Prognostic Information in Unselected Patients Hospitalized With COVID-19
por: Omland, Torbjørn, et al.
Publicado: (2020) -
SARS‐CoV‐2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID‐19
por: Myhre, Peder L., et al.
Publicado: (2021) -
Cardiac troponin I and T for ruling out coronary artery disease in suspected chronic coronary syndrome
por: Tveit, Sjur H., et al.
Publicado: (2022) -
Soluble ST2 concentrations associate with in-hospital mortality and need for mechanical ventilation in unselected patients with COVID-19
por: Omland, Torbjorn, et al.
Publicado: (2021) -
Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19
por: Myhre, Peder L., et al.
Publicado: (2020)